Skip to main content
Bio-Gate AG logo

Bio-Gate AG — Investor Relations & Filings

Ticker · BIG1 ISIN · DE000BGAG981 LEI · 391200G5LKTIOTZOXP90 F Manufacturing
Open in API
Filings indexed 242 across all filing types
Latest filing 2011-05-04 Board/Management Inform…
Country DE Germany
Listing F BIG1

About Bio-Gate AG

https://www.bio-gate.de/en/

Bio-Gate AG is a provider of innovative technologies and customized solutions for health and hygiene, specializing in antimicrobial and antiviral strategies. The company enhances materials and products by incorporating its unique silver-based technologies, such as MicroSilver BG™. Key applications are concentrated in the medical technology sector, including the coating of medical implants and wound dressings to prevent infections. The company's technologies are also utilized in derma-cosmetics and veterinary care products. Furthermore, Bio-Gate provides solutions for industrial and consumer goods, imparting antimicrobial properties to items like paints, coatings, plastics, and textiles.

Recent filings

Filing Released Lang Actions
Veranderung im Vorstand der Bio-Gate AG
Board/Management Information Classification · 100% confidence The document is titled 'Veränderung im Vorstand der Bio-Gate AG' (Change in the Management Board of Bio-Gate AG) and explicitly states that Dr. Michael Wagener has resigned from his board mandate ('Vorstandsmandat aus persönlichen Gründen niedergelegt hat'). This content directly relates to changes in senior management personnel. According to the definitions, this corresponds to Board/Management Information (MANG). The document length is short (3595 chars), but it is the primary announcement itself, not an announcement *about* a report, so RPA/RNS is not the primary classification.
2011-05-04 German
Bio-Gate AG: Bio-Gate erreicht im Geschaftsjahr 2010 die Finanzziele
Earnings Release Classification · 100% confidence The document is a news release dated February 28, 2011, titled "Bio-Gate erreicht im Geschäftsjahr 2010 die Finanzziele" (Bio-Gate achieves financial targets in fiscal year 2010). It provides preliminary, unaudited figures for the full fiscal year 2010, including revenue increase and loss reduction. Crucially, it states: "Die endgültigen Geschäftszahlen des Bio-Gate Konzerns für 2010 werden im Mai veröffentlicht" (The final business figures for Bio-Gate Group for 2010 will be published in May). This indicates the document is an initial announcement of key financial results for a period, not the comprehensive final report (10-K or IR). Therefore, it fits the definition of an Earnings Release (ER). FY 2010
2011-02-28 German
Bio-Gate setzt den Wachstumskurs wie erwartet fort
Earnings Release Classification · 100% confidence The document is a press release dated February 9, 2011, titled "Bio-Gate setzt den Wachstumskurs wie erwartet fort" (Bio-Gate continues its growth trajectory as expected). It discusses business updates, contract signings (Benjamin Moore & Co., Leggett & Platt), expansion into Asian markets, and mentions that preliminary full-year 2010 figures are expected to be published at the end of February. Crucially, it summarizes operational and financial highlights for a period (H1 2010 results mentioned) but is not the comprehensive annual report (10-K) or the formal, initial announcement of quarterly results (ER). Since it provides a detailed narrative update on business performance, strategy, and outlook, it aligns best with a Management Report (MDA) or potentially an Interim Report (IR) if it were more focused on financials. Given the focus on management commentary, business segment performance, and outlook following a period, MDA is the most appropriate classification, although it shares characteristics with an ER/IR. It is not a short announcement of a report publication (RPA/RNS) as it contains substantial content. FY 2010
2011-02-09 German
Jahresabschluss zum Geschäftsjahr vom 01.01.2009 bis zum 31.12.2009
Annual Report Classification · 100% confidence The document is a 'Jahresabschluss' (Annual Financial Statement) for Bio-Gate AG for the fiscal year 2009. It contains a balance sheet (Bilanz), detailed notes (Anhang) covering accounting principles, valuation methods, and specific disclosures regarding capital, liabilities, and board members. As it provides comprehensive financial statements for the full fiscal year, it is classified as an Annual Report (10-K equivalent in the German context). FY 2009
2010-12-09 German
Bio-Gate AG: Wegen der groen Nachfrage schliet Bio-Gate die Barkapitalerhohung mit Bezugsrecht vorzeitig ab
Share Issue/Capital Change Classification · 99% confidence The document is a corporate news release dated October 29, 2010, announcing the successful and early closure of a cash capital increase ('Barkapitalerhöhung mit Bezugsrecht'). Key phrases include 'Kapitalerhöhung' (Capital Increase), 'neues Kapital' (new capital), and details about the subscription price and funds raised (nearly EUR 2 million). This directly relates to the company's financing activities and capital structure changes. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2010-10-29 German
Bio-Gate beschliet Barkapitalerhohung zu 1,80 Euro je Aktie
Share Issue/Capital Change Classification · 98% confidence The document is a corporate news release dated October 7, 2010, announcing that Bio-Gate AG's management board has decided to increase the share capital through a cash capital increase ('Barkapitalerhöhung') at a specific price (€1.80 per share) with a subscription ratio (3:1). This action directly relates to fundraising, financing activities, and changes in the capital structure. This aligns perfectly with the definition for 'Capital/Financing Update' (CAP). Although it is a news release, the core subject matter is the capital change itself, making CAP more specific than a general RPA or RNS.
2010-10-07 German

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.